Pharmacodynamic and pharmacokinetic basics of rivaroxaban

R Kreutz - Fundamental & clinical pharmacology, 2012 - Wiley Online Library
Rivaroxaban, an oral, direct factor Xa inhibitor, is a small molecule drug capable of inhibiting
not only free factor Xa with high selectivity but also prothrombinase‐bound and clot …
被引用次数：173 相关文章

Pharmacodynamic and pharmacokinetic basics of rivaroxaban.

R Kreutz - Fundamental & Clinical Pharmacology, 2011 - europepmc.org
Rivaroxaban, an oral, direct factor Xa inhibitor, is a small molecule drug capable of inhibiting
not only free factor Xa with high selectivity but also prothrombinase-bound and clot …

Pharmacodynamic and pharmacokinetic basics of rivaroxaban.

R Kreutz - Fundamental & Clinical Pharmacology, 2012 - search.ebscohost.com
Rivaroxaban, an oral, direct factor Xa inhibitor, is a small molecule drug capable of inhibiting
not only free factor Xa with high selectivity but also prothrombinase-bound and clot …

Pharmacodynamic and pharmacokinetic basics of rivaroxaban

R Kreutz - Fundamental & Clinical Pharmacology, 2012 - infona.pl
Rivaroxaban, an oral, direct factor Xa inhibitor, is a small molecule drug capable of inhibiting
not only free factor Xa with high selectivity but also prothrombinase‐bound and clot …

[引用][C] Pharmacodynamic and pharmacokinetic basics of rivaroxaban

R KREUTZ - Fundamental & clinical pharmacology, 2012 - pascal-francis.inist.fr
Pharmacodynamic and pharmacokinetic basics of rivaroxaban CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Pharmacodynamic and pharmacokinetic basics of rivaroxaban

R Kreutz - Fundamental & Clinical Pharmacology, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Rivaroxaban, an oral, direct factor Xa inhibitor,
is a small molecule drug capable of inhibiting not only free factor Xa with high selectivity but …

Pharmacodynamic and pharmacokinetic basics of rivaroxaban

R Kreutz - Fundamental & clinical pharmacology, 2012 - pubmed.ncbi.nlm.nih.gov
Rivaroxaban, an oral, direct factor Xa inhibitor, is a small molecule drug capable of inhibiting
not only free factor Xa with high selectivity but also prothrombinase-bound and clot …

[引用][C] Pharmacodynamic and pharmacokinetic basics of rivaroxaban

R KREUTZ - Fundamental & clinical pharmacology, 2012 - Blackwell